Hearing Disorders and Deafness
Also known as: Hearing loss, Presbycusis, Ears, Aural, Auditory
Methodology & AI Transparency ⓘ
Hearing Disorders and Deafness Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: It's frustrating to be unable to hear well enough to enjoy talking with friends or family.
- 2 Real-world patient consensus: Mapped to Ear, Nose, Throat & Oral Health under ICD-10-CM H91.90 for Hearing Disorders and Deafness clinical workups.
- 3 Typical cash cost range: Differential triage of Hearing Disorders and Deafness (H91.90) utilizes preventive periodontal debridement [Hearing Disorders and Deafness H91.90].
- 4 Top reported side effects / signs: Objective lab/clinical target for Hearing Disorders and Deafness: Pure-Tone Audiometry & in Hearing Disorders and Deafness (H91.90: Tympanometry) (Thresholds <= 20 dB HL; normal middle-ear pressure (H91.90)) and Periodontal Pocket Depth in Hearing Disorders and Deafness (H91.90: & Bleeding Index).
Ask our AI Specialists anything about Hearing Disorders and Deafness
What Is Hearing Disorders and Deafness?
It's frustrating to be unable to hear well enough to enjoy talking with friends or family. Hearing disorders make it hard, but not impossible, to hear. They can often be helped. Deafness can keep you from hearing sound at all. What causes hearing loss? Some possibilities are: Heredity Diseases such as ear infections and meningitis Trauma Certain medicines Long-term exposure to loud noise Aging There are two main types of hearing loss. One happens when your inner ear or auditory nerve is damaged. This type is usually permanent. The other kind happens when sound waves cannot reach your inner ear. Earwax buildup, fluid, or a punctured eardrum can cause it.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Hearing Disorders and Deafness (ICD-10 H91.90) is driven by or endolymphatic hydrops [Hearing Disorders and Deafness H91.90]; Cross-referenced with NIH MeSH (Hearing Disorders, Deafness), specialists in Ear, Nose, Throat & Oral Health monitor Periodontal Pocket Depth in Hearing Disorders and Deafness (H91.90: & Bleeding Index) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Diseases such as ear infections and meningitis
- • Long-term exposure to loud noise
- • Presentation of Hearing Disorders and Deafness (H91.90): episodic spinning vertigo in Hearing Disorders and Deafness (H91.90: accompanied by fluctuating)
- • Secondary Hearing Disorders and Deafness clinical sign: bleeding or receding in Hearing Disorders and Deafness (H91.90: gums, tooth sensitivity,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Hearing Disorders and Deafness Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | H91.90 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Hearing Disorders and Deafness (H91.90: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (H91.90) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Hearing Disorders and Deafness (H91.90: & Bleeding Index) | Probing <= 3 mm without bleeding (H91.90) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Hearing Disorders and Deafness
Treatment selection for Hearing Disorders and Deafness depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Hearing Disorders and Deafness)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Pharmacometabolomic mapping of early biochemical changes induced by sertraline Response to drug and response to placebo share common pathways but some pathways are more affected by drug treatment. Translational psychiatry • 2013-01-22 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 23340506 ↗ |
| Can This Approach Help? Inside the Latest Research on Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Long-term high-dose intratympanic dexamethasone treatment did not prevent cisplatin-induced hearing loss. Ear and hearing • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 34483247 ↗ |
| Can This Approach Help? Inside the Latest Research on Prophylactic nimodipine treatment improves hearing outcome after vestibular The imbalance in tumor size with larger tumors in females of the treatment group may falsely suggest a gender-related effect. Neurosurgical review • 2021-06-15 • Phase III Randomized Trial | N = 21 | 82/100 | PMID 32827307 ↗ |
Hearing Disorders and Deafness Patient Community & “People Like Me” Threads
Filter Hearing Disorders and Deafness community threads and patient logs by age, biological sex, dosage, and treatment duration.